No association between low density lipoprotein receptor genetic variants and Alzheimer's disease risk

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 141, Issue 5, 2006, Pages 541-543

  Rodríguez, Eloy ^a   Mateo, Ignacio ^a   Llorca, Javier ^b   Sánchez Quintana, Coro ^a   Infante, Jon ^a   Berciano, José ^a   Combarros, Onofre ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cholesterol; Low density lipoprotein receptor; Polymorphism

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; EXON; FEMALE; GENE LOCATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR GENE; RISK FACTOR; SPAIN;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, LDL; RISK FACTORS;

EID: 33745801829     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30341     Document Type: Article

References (13)

1. Beffert U, Stolt PC, Herz J. 2004. Functions of lipoprotein receptors in neurons. J Lipid Res 45:403-409.
2. Cheng D, Huang R, Lanham IS, Cathcart HM, Howard M, Corder EH, Poduslo SE. 2005. Functional interaction between APOE4 and LDL receptor isoforms in Alzheimer's disease. J Med Genet. 42:129-131.
3. Dietschy JM, Turley SD. 2001. Cholesterol metabolism in the brain. Curr Opin Lipidol 12:105-112.
4. Gopalraj RK, Zhu H, Kelly JF, Mendiondo M, Pulliam JF, Bennett DA, Estus S. 2005. Genetic association of low density lipoprotein receptor and Alzheimer's disease. Neurobiol Aging 26:1-7.
5. Herz J. 2001. The LDL receptor gene family: (Un)expected signal transducers in the brain. Neuron 29:571-581.
6. Lendon CL, Talbot CJ, Craddock NJ, Han SW, Wragg M, Morris JC, Goate AM. 1997. Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population. Neurosci Lett 222:187-190.
7. Malloy SI, Altenburg MK, Knouff C, Lanningham-Foster L, Parks JS, Maeda N. 2004. Harmful effects of increased LDLR expression in mice with human APOE*4 but not APOE*3. Arterioscler Thromb Vasc Biol 24:91-97.
8. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer Disease. Neurology 24:939-944.
9. Michikawa M. 2003. The role of cholesterol in pathogenesis of Alzheimer's disease. Dual metabolic interaction between amyloid β-protein and cholesterol. Mol Neurohiol 27:1-12.
10. Poirier J. 2003. Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease. Trends Mol Med 9:94-101.
11. Puglielli L, Tanzi RE, Kovacs DM. 2003. Alzheimer's disease: The cholesterol connection. Nat Neurosci 6:345-351.
12. Retz W, Thome J, Durany N, Harsányi A, Retz-Junginger P, Kornhuber J, Riederer P, Rösler M. 2001. Potential genetic markers of sporadic Alzheimer's dementia. Psychiatr Genet 11:115-122.
13. Yanagisawa K. 2002. Cholesterol and pathological processes in Alzheimer's disease. J Neurosci Res 70:361-366.